Candesartan Cilexetil
Pricing Report NDC 60687-241-25

Latest NADAC: $0.56505 per EA · Effective Sep 17, 2025 · Est. package price $16.95 (30 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Candesartan Cilexetil (NDC 60687-241-25) is $0.56505 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 17, 2025.

As a provided by American Health Packaging, this medication is distributed in a 30 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET in 1 BLISTER PACK (60687-241-95) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.56505
Per EA

Effective Date
Sep 17, 2025
Billable Units
30 EA
Estimated Package Price
$16.95
Data Status
As of Oct 01, 2025
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET in 1 BLISTER PACK (60687-241-95)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2016, the NADAC wholesale price for (NDC ) has moved within a range of $0.44211 to $2.03842 per EA. Over this 8 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4421 - $2.0384
Market Volatility
361.07% Variance
Latest Trend
7.21%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 17, 2025 $0.56505 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $0.60893 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $0.59741 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $0.60464 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $0.62816 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $0.62620 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $0.63785 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $0.56834 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $0.51649 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $0.48163 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $0.44278 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $0.52278 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026